These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 11692082)

  • 1. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene.
    Mealey KL; Bentjen SA; Gay JM; Cantor GH
    Pharmacogenetics; 2001 Nov; 11(8):727-33. PubMed ID: 11692082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd.
    Geyer J; Döring B; Godoy JR; Moritz A; Petzinger E
    J Vet Pharmacol Ther; 2005 Feb; 28(1):95-9. PubMed ID: 15720521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity.
    Mealey KL; Northrup NC; Bentjen SA
    J Am Vet Med Assoc; 2003 Nov; 223(10):1453-5, 1434. PubMed ID: 14627096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States.
    Mealey KL; Bentjen SA; Waiting DK
    Am J Vet Res; 2002 Apr; 63(4):479-81. PubMed ID: 11939306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of herding breed dogs living in Australia.
    Mealey KL; Munyard KA; Bentjen SA
    Vet Parasitol; 2005 Aug; 131(3-4):193-6. PubMed ID: 15975717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin.
    Roulet A; Puel O; Gesta S; Lepage JF; Drag M; Soll M; Alvinerie M; Pineau T
    Eur J Pharmacol; 2003 Jan; 460(2-3):85-91. PubMed ID: 12559367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of collies from France.
    Hugnet C; Bentjen SA; Mealey KL
    J Vet Pharmacol Ther; 2004 Aug; 27(4):227-9. PubMed ID: 15305851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany.
    Geyer J; Döring B; Godoy JR; Leidolf R; Moritz A; Petzinger E
    J Vet Pharmacol Ther; 2005 Dec; 28(6):545-51. PubMed ID: 16343287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivermectin toxicity in an Australian Shepherd dog with the MDR1 mutation associated with ivermectin sensitivity in Collies.
    Nelson OL; Carsten E; Bentjen SA; Mealey KL
    J Vet Intern Med; 2003; 17(3):354-6. PubMed ID: 12774979
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency of the mutant MDR1 allele in dogs in the UK.
    Tappin SW; Goodfellow MR; Peters IR; Day MJ; Hall EJ; Mealey KL
    Vet Rec; 2012 Jul; 171(3):72. PubMed ID: 22735986
    [No Abstract]   [Full Text] [Related]  

  • 11. Allele-specific polymerase chain reaction diagnostic test for the functional MDR1 polymorphism in dogs.
    Baars C; Leeb T; von Klopmann T; Tipold A; Potschka H
    Vet J; 2008 Sep; 177(3):394-7. PubMed ID: 17644437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid genotyping assays for the 4-base pair deletion of canine MDR1/ABCB1 gene and low frequency of the mutant allele in Border Collie dogs.
    Mizukami K; Chang HS; Yabuki A; Kawamichi T; Hossain MA; Rahman MM; Uddin MM; Yamato O
    J Vet Diagn Invest; 2012 Jan; 24(1):127-34. PubMed ID: 22362942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel insertion mutation of ABCB1 gene in an ivermectin-sensitive Border Collie.
    Han JI; Son HW; Park SC; Na KJ
    J Vet Sci; 2010 Dec; 11(4):341-4. PubMed ID: 21113104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loperamide-induced expression of immune and inflammatory genes in Collies associated with ivermectin sensitivity.
    Zhu M; Yancy HF; Deaver C; Jones YL; Myers MJ
    J Vet Pharmacol Ther; 2016 Apr; 39(2):131-7. PubMed ID: 26471945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the nt230(del4) MDR1 mutation in White Swiss Shepherd dogs: case reports of doramectin toxicosis, breed predisposition, and microsatellite analysis.
    Geyer J; Klintzsch S; Meerkamp K; Wöhlke A; Distl O; Moritz A; Petzinger E
    J Vet Pharmacol Ther; 2007 Oct; 30(5):482-5. PubMed ID: 17803743
    [No Abstract]   [Full Text] [Related]  

  • 16. Fast and simple detection methods for the 4-base pair deletion of canine MDR1/ ABCB1 gene by PCR and isothermal amplification.
    Stiedl CP; Weber K
    J Vet Diagn Invest; 2017 Mar; 29(2):176-180. PubMed ID: 28061549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity.
    Sartor LL; Bentjen SA; Trepanier L; Mealey KL
    J Vet Intern Med; 2004; 18(1):117-8. PubMed ID: 14765742
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance and Pharmacokinetics of Galliprant™ Administered Orally to Collies Homozygous for MDR1-1Δ.
    Heit MC; Mealey KL; King SB
    J Vet Pharmacol Ther; 2021 Sep; 44(5):705-713. PubMed ID: 34219249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration.
    Walther FM; Paul AJ; Allan MJ; Roepke RK; Nuernberger MC
    Parasit Vectors; 2014 Mar; 7():86. PubMed ID: 24602342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage.
    Neff MW; Robertson KR; Wong AK; Safra N; Broman KW; Slatkin M; Mealey KL; Pedersen NC
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11725-30. PubMed ID: 15289602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.